| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |